关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 0 5 2 8 4 8 4 位浏览者
您当前的位置:首页 >> 正文

HPLC-MS法同时测定健脾益肾丸中8个成分的含量

Simultaneous determination of eight components in Jianpi Yishen pills by HPLC-MS

作者(英文):
分类号:R917
出版年·卷·期(页码):2017,37 (6):962-967
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:建立高效液相色谱-串联质谱法同时测定健脾益肾丸中8个主要成分(丹参素钠、丹酚酸B、松果菊苷、毛蕊异黄酮葡萄糖苷、毛蕊花糖苷、甘草苷、黄芪甲苷、芒柄花素)的含量。方法:采用ZORBAX C18色谱柱(250 mm×4.6 mm,5 μm),以乙腈(A)-10 mmol·L-1乙酸铵溶液(B)为流动相,梯度洗脱(0~1.2 min,5% A;1.2~2 min,5% A→20% A;2~4 min,20% A→40% A;4~8 min,40% A;8~10 min,40% A→95% A;10~17 min,95% A;17~25 min,5% A),流速为0.8 mL·min-1,进样量为5 μL;采用电喷雾离子源(ESI),SIM模式,正负离子同时检测方式。结果:丹参素钠、丹酚酸B、松果菊苷、毛蕊异黄酮葡萄糖苷、毛蕊花糖苷、甘草苷、黄芪甲苷和芒柄花素检测的线性范围分别为0.04~2.5 μg·mL-1r=0.999 7)、0.035~1.0 μg·mL-1r=0.999 5)、0.15~20 μg·mL-1r=0.999 2)、0.04~20 μg·mL-1r=0.999 8)、0.004~2.0 μg·mL-1r=0.999 9)、0.06~2.0 μg·mL-1r=0.999 4)、0.035~2.5 μg·mL-1r=0.999 8)和0.006~0.2(r=0.999 5)μg·mL-1;精密度、稳定性、重复性试验的RSD小于3%;平均回收率(n=6)均在97.0%~102%范围内,RSD均小于3%。3批样品中丹参素钠、丹酚酸B、松果菊苷、毛蕊异黄酮葡萄糖苷、毛蕊花糖苷、甘草苷、黄芪甲苷和芒柄花素含量测定结果分别为0.490~0.500、1.792~1.812、0.505~0.511、0.680~0.684、0.609~0.615、0.100~0.110、0.056~0.057和0.020~0.022 mg·g-1结论:所建立可作为健脾益肾丸的质量控制提供依据。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To establish an HPLC-MS method for the determination of eight components in Jianpi Yishen pills(sodium danshensu,salvianolic acid B,echinacoside,calycosin 7-O-glucoside,acteoside,liquiritin, astragaloside Ⅳ).Methods: Chromatographic separation was carried out at 30℃ on a C18 column(250 mm×4.6 mm,5 μm).The mobile phase consisted of acetonitrile(A)and 10 mmol·L-1 ammonium acetate(B)using a gradient elution of 0-1.2 min,5% A;1.2-2 min,5% A → 20% A;2-4 min,20% A → 40% A;4-8 min,40% A;8-10 min,40% A → 95% A;10-17 min,95% A and 17-25 min,5% A with flow rate 0.8 mL·min-1 The MS analysis worked in ESI positive and negative modes using selected ion monitoring mode.Results: The linear ranges were 0.04-2.5 μg·mL-1(r=0.999 7)for sodium danshensu,0.035-1.0 μg·mL-1(r=0.999 5)for salvianolic acid B, 0.15-20 μg·mL-1(r=0.999 2)for echinacoside, 0.04-20 μg·mL-1(r=0.999 8)for calycosin 7-O-glucoside,0.004-2.0 μg·mL-1(r=0.999 9)for acteoside,0.06-2.0 μg·mL-1(r=0.999 4)for liquiritin, 0.035-2.5 μg·mL-1(r=0.999 8)for astragaloside Ⅳ, 0.006-0.2 μg·mL-1(r=0.999 5)for formononetin, and the average recovery was between 97.0% to 102%.The contents of sodium danshensu, salvianolic acid B, echinacoside,calycosin 7-O-glucoside, acteoside,liquiritin,astragaloside Ⅳ,formononetin were 0.490-0.500 mg·g-1, 1.792-1.812 mg·g-1, 0.505-0.511 mg·g-1, 0.680-0.684 mg·g-1, 0.609-0.615 mg·g-1,0.100-0.110 mg·g-1, 0.056-0.057 mg·g-1 and 0.020-0.022 mg·g-1, respectively.Conclusion: The method can be used for the quality control of Jianpi Yishen pills.

-----参考文献:---------------------------------------------------------------------------------------

[1] 李顺民,傅博,易铁钢,等.健脾益肾方(法)治疗慢性肾功能衰竭及其营养不良的研究[J].中华中医药学刊, 2008, 26(10):2102 LI SM, FU B, YI TG, et al. Research on chronic renal failure and malnutrition treated with Jianpi Yishen decoction[J]. Chin Arch Tradit Chin Med, 2008, 26(10):2102
[2] 李顺民,杨曙东. 健脾益肾方治疗脾肾气虚型慢性肾功能衰竭46例疗效观察[J]. 新中医,2005, 37(10):36 LI SM, YANG SD. Clinical study of Jianpi Yishen decoction on patients with CRF[J]. New J Tradit Chin Med, 2005, 37(10):36
[3] 中国药典2015年版.一部[S]. 2015:302 ChP 2015. Vol Ⅰ[S]. 2015:302
[4] SUN H,WANG W,HAN P,et al. Astragaloside Ⅳ ameliorates renal injury in db/db mice[J]. Sci Rep, 2016,6:32545
[5] ZHENG KYZ, CHOI RCY, CHEUNG AWH, et al. Flavonoids from Radix Astragali induce the expression of erythropoietin in cultured cells:A signaling mediated via the accumulation of hypoxiainducible factor-1 alpha[J]. J Agric Food Chem, 2011, 59(5):1697
[6] CUI Q, PAN Y, BAI X, et al. Systematic characterization of the metabolites of echinacoside and acteoside from Cistanche tubulosa in rat plasma, bile, urine and feces based on UPLC-ESI-Q-TOF-MS[J]. Biomed Chromatogr, 2016,30(9):1406
[7] JIANG Z,WANG J,LI X,et al. Echinacoside and Cistanche tubulosa (Schenk)R. wight ameliorate bisphenol A-induced testicular and sperm damage in rats through gonad axis regulated steroidogenic enzymes[J]. J Ethnopharmacol, 2016, 193:321
[8] YUAN J, REN J, WANG Y, et al. Acteoside binds to caspase-3 and exerts neuroprotection in the rotenone rat model of Parkinson's disease[J]. PLoS One,2016, 11(9):e0162696
[9] 马丙祥,董宠凯.丹参的药理作用研究新进展[J]. 中国药房, 2014,25(7):663 MA BX, DONG CK. A recent pharmacological study on Salvia miltiorrhiza[J]. China Pharm, 2014, 25(7):663
[10] 孙仁弟,徐向阳,宋燕青.丹酚酸B的药理研究进展[J].药物流行病学杂志,2012, 20(9):458 SUN RD, XU XY, SONG YQ. A recent pharmacological study on salvianolic acid B[J]. Chin J Pharmacoepidemiol, 2012, 21(9):458
[11] LIU D, LIU S, YU X, et al. Salvianolic acid B prevents iodinated contrast media-induced acute renal injury in rats via the PI3K/Akt/Nrf2 pathway[J]. Oxid Med Cell Longev,2016:e7079487
[12] LAM CT, CHAN PH, LEE PS, et al. Chemical and biological assessment of Jujube(Ziziphus jujuba)-containing herbal decoctions:induction of erythropoietin expression in cultures. J Chromatogr B,2016, 1026:254
[13] ZHANG Y, ZHANG L, ZHANG Y, et al. The protective role of liquiritin in high fructose-induced myocardial fibrosis via inhibiting NF-κB and MAPK signaling pathway[J]. Biomed Pharmacother, 2016,84:1337
[14] 崔萍,杨莉,熊爱珍,等. UPLC-MS法测定消肿片中3个乌头碱类双酯型生物碱的含量[J].药物分析杂志,2012, 32(5):868 CUI P, YANG L, XIONG AZ, et al. Quantification of three aconitine-type diester alkaloids in Xiaozhong tablets by UPLC-MS[J]. Chin J Pharm Anal, 2012,32(5):868
[15] 刘灵改,支旭然,郭进,等. HPLC-MS法同时测定防芷鼻咽颗粒中6个成分的含量[J].药物分析杂志,2014, 34(5):830 LIU LG, ZHI XR, GUO J, et al. Simultaneous determination of 6 compounds in Fangzhi nasopharyngeal granules by HPLC-MS[J]. Chin J Pharm Anal, 2014, 34(5):830

欢迎阅读《药物分析杂志》!您是该文第 418位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn